Novasight Hybrid Intravascular Ultrasound and Optical Coherence Tomography System (IVUS OCT)
1 other identifier
interventional
23
1 country
1
Brief Summary
Collection of coronary images with a hybrid IVUS OCT system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2018
CompletedFirst Posted
Study publicly available on registry
April 2, 2018
CompletedStudy Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 6, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 18, 2021
CompletedAugust 31, 2021
August 1, 2021
1 year
March 12, 2018
August 28, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Collection of the first human coronary images with the hybrid IVUS OCT technology
The hybrid IVUS OCT system permits simultaneous and co-registered acquisition of IVUS and OCT coronary images. IVUS and/or OCT series can be recorded up to 10 cm of the vessel length or up to 20 s of imaging. The physician will review 10 frames and evaluate independently IVUS images, OCT images and the combined IVUS-OCT images for the ability to identify and characterize coronary lesion categories: lipid plaque, calcified plaque, fibrous plaque, thin fibrous cap, positive remodelling and plaque burden. Results, for each frame and imaging modality, of lesion assessment will be tabulated as: a) non-assessable, b) assessable and present, c) assessable and absent. The Clinical Report Form captures tabulated sections for each imaging modality and specific frame selected for lesion evaluation. Results will be presented qualitatively and quantitative as categorical calculations. Image interpretation will be performed independently and blinded to clinical and angiographic information.
Clinical Report Forms (capturing image analysis) will be completed for each case no later then 72 hours after the procedure.
Study Arms (1)
Observation group
OTHERPatients undergoing coronary angiography and intravascular imaging for either diagnostic purposes or for PCI following a presentation with either stable angina or an acute coronary syndrome.
Interventions
Eligibility Criteria
You may qualify if:
- Patient is at least 18 years old.
- Patients arriving for coronary angiography or possible PCI with stable angina or acute coronary syndrome (including unstable angina, NSTEMI or STEMI).
- Patients with STEMI may be undergoing subsequent staged PCI to additional coronary stenoses after the index STEMI event has been successful treated with primary PCI.
- Vascular access of at least 6F.
- Patient provides informed, written consent for participation in the study.
- A target lesion is present in a suitable artery for intravascular imaging.
You may not qualify if:
- Angiographic evidence of severe calcification
- Marked tortuosity that precludes imaging of a target coronary artery.
- GFR (Glomerular filtration rate) \<35 mL/min.
- Patients in cardiogenic shock.
- Women of child bearing potential, in whom pregnancy cannot be excluded.
- Patients of age \< 18 years old.
- Patients with an allergy to contrast.
- Patients unable to grant informed, written consent for participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Conavilead
Study Sites (1)
Hamilton General Hospital
Hamilton, Ontario, L8L 2X2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tej Sheth, MD
Hamilton General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2018
First Posted
April 2, 2018
Study Start
August 1, 2018
Primary Completion
August 6, 2019
Study Completion
August 18, 2021
Last Updated
August 31, 2021
Record last verified: 2021-08